Convolutional neural networks for classification of Alzheimer's disease: Overview and reproducible evaluation
- PMID: 32417716
- DOI: 10.1016/j.media.2020.101694
Convolutional neural networks for classification of Alzheimer's disease: Overview and reproducible evaluation
Abstract
Numerous machine learning (ML) approaches have been proposed for automatic classification of Alzheimer's disease (AD) from brain imaging data. In particular, over 30 papers have proposed to use convolutional neural networks (CNN) for AD classification from anatomical MRI. However, the classification performance is difficult to compare across studies due to variations in components such as participant selection, image preprocessing or validation procedure. Moreover, these studies are hardly reproducible because their frameworks are not publicly accessible and because implementation details are lacking. Lastly, some of these papers may report a biased performance due to inadequate or unclear validation or model selection procedures. In the present work, we aim to address these limitations through three main contributions. First, we performed a systematic literature review. We identified four main types of approaches: i) 2D slice-level, ii) 3D patch-level, iii) ROI-based and iv) 3D subject-level CNN. Moreover, we found that more than half of the surveyed papers may have suffered from data leakage and thus reported biased performance. Our second contribution is the extension of our open-source framework for classification of AD using CNN and T1-weighted MRI. The framework comprises previously developed tools to automatically convert ADNI, AIBL and OASIS data into the BIDS standard, and a modular set of image preprocessing procedures, classification architectures and evaluation procedures dedicated to deep learning. Finally, we used this framework to rigorously compare different CNN architectures. The data was split into training/validation/test sets at the very beginning and only the training/validation sets were used for model selection. To avoid any overfitting, the test sets were left untouched until the end of the peer-review process. Overall, the different 3D approaches (3D-subject, 3D-ROI, 3D-patch) achieved similar performances while that of the 2D slice approach was lower. Of note, the different CNN approaches did not perform better than a SVM with voxel-based features. The different approaches generalized well to similar populations but not to datasets with different inclusion criteria or demographical characteristics. All the code of the framework and the experiments is publicly available: general-purpose tools have been integrated into the Clinica software (www.clinica.run) and the paper-specific code is available at: https://github.com/aramis-lab/AD-DL.
Keywords: Alzheimer's disease classification Magnetic resonance imaging; Convolutional neural network Reproducibility.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest OC reports having received speaker fees from Roche (2015), Lundbeck (2012) and Guerbet (2010), having received consulting fees from AskBio (2020), having received fees for writing a lay audience short paper from Expression Santé (2019), having received speaker fees for a lay audience presentation from Palais de la Découverte (2017) and that his laboratory has received grants (paid to the institution) from EISAI (2007-2011), Air Liquide Medical Systems (2011-2016), Qynapse (2017-present) and my Brain Technologies (2016-present). His spouse is an employee at my Brain Technologies (2015-).
Similar articles
-
Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data.Neuroimage. 2018 Dec;183:504-521. doi: 10.1016/j.neuroimage.2018.08.042. Epub 2018 Aug 18. Neuroimage. 2018. PMID: 30130647
-
Reproducible Evaluation of Diffusion MRI Features for Automatic Classification of Patients with Alzheimer's Disease.Neuroinformatics. 2021 Jan;19(1):57-78. doi: 10.1007/s12021-020-09469-5. Neuroinformatics. 2021. PMID: 32524428
-
Automated MRI-Based Deep Learning Model for Detection of Alzheimer's Disease Process.Int J Neural Syst. 2020 Jun;30(6):2050032. doi: 10.1142/S012906572050032X. Int J Neural Syst. 2020. PMID: 32498641
-
A review of the application of three-dimensional convolutional neural networks for the diagnosis of Alzheimer's disease using neuroimaging.Rev Neurosci. 2023 Feb 2;34(6):649-670. doi: 10.1515/revneuro-2022-0122. Print 2023 Aug 28. Rev Neurosci. 2023. PMID: 36729918 Review.
-
MRI Segmentation and Classification of Human Brain Using Deep Learning for Diagnosis of Alzheimer's Disease: A Survey.Sensors (Basel). 2020 Jun 7;20(11):3243. doi: 10.3390/s20113243. Sensors (Basel). 2020. PMID: 32517304 Free PMC article. Review.
Cited by
-
Multi-scale graph-based grading for Alzheimer's disease prediction.Med Image Anal. 2021 Jan;67:101850. doi: 10.1016/j.media.2020.101850. Epub 2020 Oct 6. Med Image Anal. 2021. PMID: 33075641 Free PMC article.
-
New Horizons: Artificial Intelligence Tools for Managing Osteoporosis.J Clin Endocrinol Metab. 2023 Mar 10;108(4):775-783. doi: 10.1210/clinem/dgac702. J Clin Endocrinol Metab. 2023. PMID: 36477337 Free PMC article.
-
Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.Res Sq [Preprint]. 2023 Nov 8:rs.3.rs-3569391. doi: 10.21203/rs.3.rs-3569391/v1. Res Sq. 2023. Update in: Alzheimers Res Ther. 2024 Mar 19;16(1):61. doi: 10.1186/s13195-024-01428-5. PMID: 37986841 Free PMC article. Updated. Preprint.
-
Deep learning prediction of mild cognitive impairment conversion to Alzheimer's disease at 3 years after diagnosis using longitudinal and whole-brain 3D MRI.PeerJ Comput Sci. 2021 May 25;7:e560. doi: 10.7717/peerj-cs.560. eCollection 2021. PeerJ Comput Sci. 2021. PMID: 34141888 Free PMC article.
-
Machine Learning and Image Processing Enabled Evolutionary Framework for Brain MRI Analysis for Alzheimer's Disease Detection.Comput Intell Neurosci. 2022 Mar 27;2022:5261942. doi: 10.1155/2022/5261942. eCollection 2022. Comput Intell Neurosci. 2022. Retraction in: Comput Intell Neurosci. 2023 Jul 26;2023:9817176. doi: 10.1155/2023/9817176. PMID: 35419043 Free PMC article. Retracted.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous